Elisabeta Comsa

Methyl-cyclopentadienyl Ruthenium Compounds with 2,2'-Bipyridine Derivatives Display Strong Anticancer Activity and Multidrug Resistance Potential.

P. Falson, J. P. P. Ramalho, F. Marques, 2018, Inorganic chemistry.

Ovarian cancer cells cisplatin sensitization agents selected by mass cytometry target ABCC2 inhibition.

P. Falson, T. Andrieu, A. Boumendjel, 2018, Future medicinal chemistry.

Flavonoid dimers are highly potent killers of multidrug resistant cancer cells overexpressing MRP1

L. Chow, A. di Pietro, P. Falson, 2017, Biochemical pharmacology.

Polymer "ruthenium-cyclopentadienyl" conjugates - New emerging anti-cancer drugs.

V. Labas, P. Falson, P. Zinck, 2019, European journal of medicinal chemistry.